loading...| Preferred Name |
valrubicin |
|
| Synonyms |
(2S-cis)-pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphth acenyl)-2-oxoethyl ester AD 32 NSC-246131 Valtaxin Valstar adriamycin, trifluoroacetyl-, 14-valerate N-trifluoroacetyladriamycin 14-valerate AD-32 |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C016163 |
|
| altLabel |
(2S-cis)-pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphth acenyl)-2-oxoethyl ester AD 32 NSC-246131 Valtaxin Valstar adriamycin, trifluoroacetyl-, 14-valerate N-trifluoroacetyladriamycin 14-valerate AD-32 |
|
| cui |
C0101466 C0133123 C0724176 C0068314 C1519947 |
|
| Has mapping qualifier | ||
| HM |
D004317/Q000031 |
|
| Inverse of RB |
2C6NUM6878 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19780101 |
|
| MeSH Frequency |
84 |
|
| MMR |
20220902 |
|
| notation |
C016163 |
|
| PA |
D059005 D000970 |
|
| prefLabel |
valrubicin |
|
| RR |
56124-62-0 (valrubicin) |
|
| SC |
1 |
|
| SRC |
J Histochem Cytochem 1979;27(12):1655 J Natl Cancer Inst 61(6):1521;1978 J Pharmacol Exp Ther 204(3):696;1978 Cancer Res 39(2):448;1979 Cancer Treat Rep 62(1):105-19;1978 Cancer Res 38(11):3944;1978 Cancer Treat Rep 63(5):875;1979 Cancer Res 39(2):360;1979 Cancer Treat Rep 63(5):919;1979 |
|
| TERMUI |
T001124393 T095971 T095972 T620413 T001124392 T095974 T095969 T095973 T095970 |
|
| TH |
US CA FDA SRS (2017) NLM (1978) NLM (2022) USAN (19XX) INN (19XX) USP (19XX) |
|
| tui |
T109 T195 T121 |